Search research articles
Contact Us
Filters
Showing results (21-30 of 30) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 30 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 2, 2026
LRRC15-CAR T cells for the treatment of osteosarcoma
Carla O'Reilly, Shraddha Tuladhar, Phuong Nguyen, et al.
Cancer Research Communications
|
November 16, 2023
CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma Activity
Dalia Haydar, Jorge Ibañez-Vega, Jeremy Chase Crawford, et al.
Cytotherapy
|
June 4, 2026
Successful autologous T cell apheresis in pediatric patients with hematologic malignancies, solid tumors, and brain tumors
Devin Murphy, Yu Bi, Aysha Patel, et al.
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
Targeting Regnase-1 unleashes CAR T cell antitumor activity for osteosarcoma and creates a proinflammatory tumor microenvironment
Adeleye O Adeshakin, Hao Shi, S Scott Perry, et al.
Nature
|
June 22, 2022
cBAF complex components and MYC cooperate early in CD8<sup>+</sup> T cell fate
Ao Guo, Hongling Huang, Zhexin Zhu, et al.
Nature
|
June 24, 2026
Author Correction: cBAF complex components and MYC cooperate early in CD8<sup>+</sup> T cell fate
Ao Guo, Hongling Huang, Zhexin Zhu, et al.
Nature Communications
|
July 17, 2020
Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma
Meenakshi Hegde, Sujith K Joseph, Farzana Pashankar, et al.
Science (New York, N.Y.)
|
October 10, 2024
Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy
Tae Gun Kang, Xin Lan, Tian Mi, et al.
Nature Cancer
|
April 24, 2024
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial
Meenakshi Hegde, Shoba Navai, Christopher DeRenzo, et al.
Cell Reports. Medicine
|
March 20, 2024
DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma
Allison M Kirk, Jeremy Chase Crawford, Ching-Heng Chou, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 30) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 30 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 2, 2026
LRRC15-CAR T cells for the treatment of osteosarcoma
Carla O'Reilly, Shraddha Tuladhar, Phuong Nguyen, et al.
Cancer Research Communications
|
November 16, 2023
CAR T-cell Design-dependent Remodeling of the Brain Tumor Immune Microenvironment Modulates Tumor-associated Macrophages and Anti-glioma Activity
Dalia Haydar, Jorge Ibañez-Vega, Jeremy Chase Crawford, et al.
Cytotherapy
|
June 4, 2026
Successful autologous T cell apheresis in pediatric patients with hematologic malignancies, solid tumors, and brain tumors
Devin Murphy, Yu Bi, Aysha Patel, et al.
Biorxiv : the Preprint Server for Biology
|
June 6, 2025
Targeting Regnase-1 unleashes CAR T cell antitumor activity for osteosarcoma and creates a proinflammatory tumor microenvironment
Adeleye O Adeshakin, Hao Shi, S Scott Perry, et al.
Nature
|
June 22, 2022
cBAF complex components and MYC cooperate early in CD8<sup>+</sup> T cell fate
Ao Guo, Hongling Huang, Zhexin Zhu, et al.
Nature
|
June 24, 2026
Author Correction: cBAF complex components and MYC cooperate early in CD8<sup>+</sup> T cell fate
Ao Guo, Hongling Huang, Zhexin Zhu, et al.
Nature Communications
|
July 17, 2020
Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma
Meenakshi Hegde, Sujith K Joseph, Farzana Pashankar, et al.
Science (New York, N.Y.)
|
October 10, 2024
Epigenetic regulators of clonal hematopoiesis control CD8 T cell stemness during immunotherapy
Tae Gun Kang, Xin Lan, Tian Mi, et al.
Nature Cancer
|
April 24, 2024
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial
Meenakshi Hegde, Shoba Navai, Christopher DeRenzo, et al.
Cell Reports. Medicine
|
March 20, 2024
DNAJB1-PRKACA fusion neoantigens elicit rare endogenous T cell responses that potentiate cell therapy for fibrolamellar carcinoma
Allison M Kirk, Jeremy Chase Crawford, Ching-Heng Chou, et al.
Page
of 3